BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9605051)

  • 1. Direct medical costs of coronary artery disease in the United States.
    Russell MW; Huse DM; Drowns S; Hamel EC; Hartz SC
    Am J Cardiol; 1998 May; 81(9):1110-5. PubMed ID: 9605051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical costs of coronary artery disease in the United States.
    Wittels EH; Hay JW; Gotto AM
    Am J Cardiol; 1990 Feb; 65(7):432-40. PubMed ID: 2305682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the clinical and economic burden of coronary artery disease: 1986-1998.
    Eisenstein EL; Shaw LK; Anstrom KJ; Nelson CL; Hakim Z; Hasselblad V; Mark DB
    Med Care; 2001 Aug; 39(8):824-35. PubMed ID: 11468501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of illness of chronic angina.
    Javitz HS; Ward MM; Watson JB; Jaana M
    Am J Manag Care; 2004 Oct; 10(11 Suppl):S358-69. PubMed ID: 15603245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of coronary heart disease and stroke: the case of Sweden.
    Zethraeus N; Molin T; Henriksson P; Jönsson B
    J Intern Med; 1999 Aug; 246(2):151-9. PubMed ID: 10447784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation.
    Shaw LJ; Merz CN; Pepine CJ; Reis SE; Bittner V; Kip KE; Kelsey SF; Olson M; Johnson BD; Mankad S; Sharaf BL; Rogers WJ; Pohost GM; Sopko G;
    Circulation; 2006 Aug; 114(9):894-904. PubMed ID: 16923752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs of management of patients with coronary artery disease in Poland: the multicenter RECENT study.
    Jaworski R; Jankowska EA; Ponikowski P; Banasiak W
    Pol Arch Med Wewn; 2012; 122(12):599-607. PubMed ID: 23160000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute coronary syndromes in Europe: 1-year costs and outcomes.
    Taylor MJ; Scuffham PA; McCollam PL; Newby DE
    Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic burden of depression in the United States: how did it change between 1990 and 2000?
    Greenberg PE; Kessler RC; Birnbaum HG; Leong SA; Lowe SW; Berglund PA; Corey-Lisle PK
    J Clin Psychiatry; 2003 Dec; 64(12):1465-75. PubMed ID: 14728109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Johnson BD; Shaw LJ; Buchthal SD; Bairey Merz CN; Kim HW; Scott KN; Doyle M; Olson MB; Pepine CJ; den Hollander J; Sharaf B; Rogers WJ; Mankad S; Forder JR; Kelsey SF; Pohost GM;
    Circulation; 2004 Jun; 109(24):2993-9. PubMed ID: 15197152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of coronary heart disease in the UK.
    Liu JL; Maniadakis N; Gray A; Rayner M
    Heart; 2002 Dec; 88(6):597-603. PubMed ID: 12433888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative cost comparison of treatments for coronary artery disease: the First Year Follow-Up of MASS II Study.
    Favarato D; Hueb W; Gersh BJ; Soares PR; Cesar LA; da Luz PL; Oliveira SA; Ramires JA;
    Circulation; 2003 Sep; 108 Suppl 1():II21-3. PubMed ID: 12970202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of eptifibatide in acute coronary syndromes; an economic analysis of Western European patients enrolled in the PURSUIT trial. The Platelet IIa/IIb in unstable Angina: Receptor Suppression Using Integrilin Therapy.
    Brown RE; Henderson RA; Koster D; Hutton J; Simoons ML
    Eur Heart J; 2002 Jan; 23(1):50-8. PubMed ID: 11741362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.
    Grosse SD; Nelson RE; Nyarko KA; Richardson LC; Raskob GE
    Thromb Res; 2016 Jan; 137():3-10. PubMed ID: 26654719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The socioeconomic burden of coronary heart disease in Korea.
    Chang HS; Kim HJ; Nam CM; Lim SJ; Jang YH; Kim S; Kang HY
    J Prev Med Public Health; 2012 Sep; 45(5):291-300. PubMed ID: 23091654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lack of obstructive coronary artery disease on coronary CT angiography safely reduces downstream cost and resource utilization during subsequent chest pain presentations.
    Thomas DM; Shaw DJ; Barnwell ML; Jones RL; Ahmadian HR; Prentice RL; Lin CK; Triana T; Cheezum MK; Cury RC; Slim AM
    J Cardiovasc Comput Tomogr; 2015; 9(4):329-36. PubMed ID: 26088380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic Burden of Psoriasis in the United States: A Systematic Review.
    Brezinski EA; Dhillon JS; Armstrong AW
    JAMA Dermatol; 2015 Jun; 151(6):651-8. PubMed ID: 25565304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Annual Burden of Seasonal Influenza in the US Veterans Affairs Population.
    Young-Xu Y; van Aalst R; Russo E; Lee JK; Chit A
    PLoS One; 2017; 12(1):e0169344. PubMed ID: 28046080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Economic Burden of Chronic Psychotic Disorders in Ontario.
    de Oliveira C; Cheng J; Rehm J; Kurdyak P
    J Ment Health Policy Econ; 2016 Dec; 19(4):181-192. PubMed ID: 27991417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United States.
    Strollo SE; Adjemian J; Adjemian MK; Prevots DR
    Ann Am Thorac Soc; 2015 Oct; 12(10):1458-64. PubMed ID: 26214350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.